Murine leukemia viruses: Objects and organisms

Advances in Virology

Volumn 2011, Issue , 2011, Pages

  Rein, Alan ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MURINE LEUKEMIA VIRUS;

EID: 84857035733     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2011/403419     Document Type: Review

References (128)

1. Linial M. L., Fauquet C. M., Mayo M. A., Maniloff J., Desselberger U., Ball L. A., Retroviridae. Virus taxonomy: classification and nomenclature of viruses. Proceedings of the International Committee on Taxonomy of Viruses 2004 San Diego, Calif, USA Elsevier/Academic Press 421 440
2. Gross L., "Spontaneous" leukemia developing in C3H mice following inoculation in infancy, with AK-leukemic extracts, or AK-embrvos. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 1951 76 1 27 32 2-s2.0-0001815423
3. Gross L., Development and serial cellfree passage of a highly potent strain of mouse leukemia virus. Proceedings of the Society for Experimental Biology and Medicine 1957 94 767 771
4. Moloney J. B., Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations. Journal of the National Cancer Institute 1960 24 933 951 2-s2.0-0001287226
5. Lewis P. F., Emerman M., Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. Journal of Virology 1994 68 1 510 516 2-s2.0-0028055281
6. Roe T., Reynolds T. C., Yu G., Brown P. O., Integration of murine leukemia virus DNA depends on mitosis. EMBO Journal 1993 12 5 2099 2108 2-s2.0-0027158091
7. Jarrosson-Wuilleme L., Goujon C., Bernaud J., Rigal D., Darlix J. L., Cimarelli A., Transduction of nondividing human macrophages with gammaretrovirus-derived vectors. Journal of Virology 2006 80 3 1152 1159 2-s2.0-31144434399 10.1128/JVI.80.3.1152-1159.2006
8. Liu X. H., Xu W., Russ J., Eiden L. E., Eiden M. V., eidenm@mail.nih.gov The host range of gammaretroviruses and gammaretroviral vectors includes post-mitotic neural cells. PLoS ONE 2011 6 3 10.1371/journal.pone.0018072 e18072
9. Yeager M., Wilson-Kubalek E. M., Weiner S. G., Brown P. O., Rein A., Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proceedings of the National Academy of Sciences of the United States of America 1998 95 13 7299 7304 2-s2.0-0032560502 10.1073/pnas.95.13.7299
10. Ott D. E., Cellular proteins detected in HIV-1. Reviews in Medical Virology 2008 18 3 159 175 2-s2.0-43749122571 10.1002/rmv.570
11. Bubbers J. E., Lilly F., Selective incorporation of H 2 antigenic determinants into Friend virus particles. Nature 1977 266 5601 458 459 2-s2.0-0017581358
12. Albritton L. M., Tseng L., Scadden D., Cunningham J. M., A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1989 57 4 659 666 2-s2.0-0024370460
13. Battini J. L., Rasko J. E. J., Miller A. D., A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proceedings of the National Academy of Sciences of the United States of America 1999 96 4 1385 1390 2-s2.0-0033573904 10.1073/pnas.96.4.1385
14. Tailor C. S., Nouri A., Lee C. G., Kozak C., Kabat D., Cloning and characterization of a cell surface receptor for xenotropic and polytropic marine leukemia viruses. Proceedings of the National Academy of Sciences of the United States of America 1999 96 3 927 932 2-s2.0-0033514357
15. Yang Y. L., Guo L., Xu S., Holland C. A., Kitamura T., Hunter K., Cunningham J. M., Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nature Genetics 1999 21 2 216 219 2-s2.0-0032964564 10.1038/6005
16. Miller D. G., Miller A. D., A family of retroviruses that utilize related phosphate transporters for cell entry. Journal of Virology 1994 68 12 8270 8276 2-s2.0-0028072043
17. Wilson C. A., Farrell K. B., Eiden M. V., Properties of a unique form of the murine amphotropic leukemia virus receptor expressed on hamster cells. Journal of Virology 1994 68 12 7697 7703 2-s2.0-0028029747
18. Shinnick T. M., Lerner R. A., Sutcliffe J. G., Nucleotide sequence of Moloney murine leukaemia virus. Nature 1981 293 5833 543 548 2-s2.0-0019856424
19. Badorrek C. S., Weeks K. M., RNA flexibility in the dimerization domain of a gamma retrovirus. Nature Chemical Biology 2005 1 2 104 111 2-s2.0-27744554044 10.1038/nchembio712
20. Gherghe C., Lombo T., Leonard C. W., Datta S. A. K., Bess J. W., Gorelick R. J., Rein A., Weeks K. M., Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome. Proceedings of the National Academy of Sciences of the United States of America 2010 107 45 19248 19253 2-s2.0-78650628290 10.1073/pnas.1006897107
21. Rein A., Datta S. A., Jones C. P., Musier-Forsyth K., Diverse interactions of retroviral Gag proteins with RNAs. Trends in Biochemical Sciences 2011 36 7 373 380
22. Yang H., Wang J., Jia X., McNatt M. W., Zang T., Pan B., Meng W., Wang H. W., Bieniasz P. D., Xiong Y., Structural insight into the mechanisms of enveloped virus tethering by tetherin. Proceedings of the National Academy of Sciences of the United States of America 2010 107 43 18428 18432 2-s2.0-78649845815 10.1073/pnas.1011485107
23. Pornillos O., Garrus J. E., Sundquist W. I., Mechanisms of enveloped RNA virus budding. Trends in Cell Biology 2002 12 12 569 579 2-s2.0-0036900880 10.1016/S0962-8924(02)02402-9
24. Felsenstein K. M., Goff S. P., Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing. Journal of Virology 1988 62 6 2179 2182 2-s2.0-0023891579
25. Feng Y. X., Yuan H., Rein A., Levin J. G., Bipartite signal for read-through suppression in murine leukemia virus mRNA: an eight-nucleotide purine-rich sequence immediately downstream of the gag termination codon followed by an RNA pseudoknot. Journal of Virology 1992 66 8 5127 5132 2-s2.0-0026748340
26. Yoshinaka Y., Katoh I., Copeland T. D., Oroszlan S., Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon. Proceedings of the National Academy of Sciences of the United States of America 1985 82 6 1618 1622 2-s2.0-0040870513
27. Feng Y. X., Copeland T. D., Oroszlan S., Rein A., Levin J. G., Identification of amino acids inserted during suppression of UAA and UGA termination codons at the gag-pol junction of Moloney murine leukemia virus. Proceedings of the National Academy of Sciences of the United States of America 1990 87 22 8860 8863 2-s2.0-0025203579 10.1073/pnas.87.22.8860
28. Feng Y. X., Levin J. G., Hatfield D. L., Schaefer T. S., Gorelick R. J., Rein A., Suppression of UAA and UGA termination codons in mutant murine leukemia viruses. Journal of Virology 1989 63 6 2870 2873 2-s2.0-0024394624
29. Jacks T., Power M. D., Masiarz F. R., Luciw P. A., Barr P. J., Varmus H. E., Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 1988 331 6153 280 283 2-s2.0-0023870815
30. Jacks T., Varmus H. E., Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting. Science 1985 230 4731 1237 1242 2-s2.0-0022411386
31. Hatfield D. L., Levin J. G., Rein A., Oroszlan S., Translational suppression in retroviral GENE expression. Advances in Virus Research 1992 41 193 239 2-s2.0-0026462393 10.1016/S0065-3527(08)60037-8
32. Brown P. O., Coffin J. M., Hughes S. H., Varmus H. E., Integration. Retroviruses 1997 Plainview, NY, USA Cold Spring Harbor Laboratory Press 161 203
33. Colicelli J., Goff S. P., Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site. Cell 1985 42 2 573 580 2-s2.0-0022318818
34. Colicelli J., Goff S. P., Sequence and spacing requirements of a retrovirus integration site. Journal of Molecular Biology 1988 199 1 47 59 2-s2.0-0024278041
35. Rulli S. J. Jr., Hibbert C. S., Mirro J., Pederson T., Biswal S., Rein A., Selective and nonselective packaging of cellular RNAs in retrovirus particles. Journal of Virology 2007 81 12 6623 6631 2-s2.0-34249939912 10.1128/JVI.02833-06
36. D'Souza V., Summers M. F., Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus. Nature 2004 431 7008 586 590 2-s2.0-4944256277 10.1038/nature02944
37. Konings D. A. M., Nash M. A., Maizel J. V., Arlinghaus R. B., Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus. Journal of Virology 1992 66 2 632 640 2-s2.0-0026544013
38. Gherghe C., Leonard C. W., Gorelick R. J., Weeks K. M., Secondary structure of the mature ex virio Moloney murine leukemia virus genomic RNA dimerization domain. Journal of Virology 2010 84 2 898 906 2-s2.0-73849110514 10.1128/JVI.01602-09
39. Kim C. H., Tinoco I Jr., A retroviral RNA kissing complex containing only two G · C base pairs. Proceedings of the National Academy of Sciences of the United States of America 2000 97 17 9396 9401 2-s2.0-0034662880
40. Levinson B., Khoury G., Vande Woude G., Gruss P., Activation of SV40 genome by 72-base pair tandem repeats of Moloney sarcoma virus. Nature 1982 295 5850 568 572 2-s2.0-0020486150 10.1038/295568a0
41. Rabson A. B., Graves B. J., Coffin J. M., Hughes S. H., Varmus H. E., Synthesis and processing of viral RNA. Retroviruses 1997 New York, NY, USA Cold Spring Harbor Laboratory Press 205 262
42. Henderson L. E., Krutzsch H. C., Oroszlan S., Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational protein modification. Proceedings of the National Academy of Sciences of the United States of America 1983 80 2 339 343 2-s2.0-0020650110
43. Rein A., McClure M. R., Rice N. R., Luftig R. B., Schultz A. M., Myristylation site in Pr65(gag) is essential for virus particle formation by Moloney murine leukemia virus. Proceedings of the National Academy of Sciences of the United States of America 1986 83 19 7246 7250 2-s2.0-0022794486
44. Yuan B., Campbell S., Bacharach E., Rein A., Goff S. P., Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. Journal of Virology 2000 74 16 7250 7260 2-s2.0-0033854158 10.1128/JVI.74.16.7250-7260.2000
45. Segura-Morales C., Pescia C., Chatellard-Causse C., Sadoul R., Bertrand E., Basyuk E., Tsg101 and Alix interact with murine leukemia virus Gag and cooperate with Nedd4 ubiquitin ligases during budding. Journal of Biological Chemistry 2005 280 29 27004 27012 2-s2.0-22844435415 10.1074/jbc.M413735200
46. Prizan-Ravid A., Elis E., Laham-Karam N., Selig S., Ehrlich M., Bacharach E., eranbac@post.tau.ac.il The Gag cleavage product, p12, is a functional constituent of the murine leukemia virus pre-integration complex. PLoS Pathogens 2010 6 11 10.1371/journal.ppat.1001183 e1001183
47. Yuan B., Fassati A., Yueh A., Goff S. P., Characterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection. Journal of Virology 2002 76 21 10801 10810 2-s2.0-0036838211 10.1128/JVI.76.21.10801-10810.2002
48. Yueh A., Goff S. P., Phosphorylated serine residues and an arginine-rich domain of the Moloney murine leukemia virus p12 protein are required for early events of viral infection. Journal of Virology 2003 77 3 1820 1829 2-s2.0-0037302292 10.1128/JVI.77.3.1820-1829.2003
49. Auerbach M. R., Shu C., Kaplan A., Singh I. R., Functional characterization of a portion of the Moloney murine leukemia virus gag gene by genetic footprinting. Proceedings of the National Academy of Sciences of the United States of America 2003 100 20 11678 11683 2-s2.0-0141705358 10.1073/pnas.2034020100
50. Yuan B., Li X., Goff S. P., Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO Journal 1999 18 17 4700 4710 2-s2.0-0344035661 10.1093/emboj/18.17.4700
51. Oshima M., Muriaux D., Mirro J., Nagashima K., Dryden K., Yeager M., Rein A., Effects of blocking individual maturation cleavages in murine leukemia virus Gag. Journal of Virology 2004 78 3 1411 1420 2-s2.0-0347003561 10.1128/JVI.78.3.1411-1420.2004
52. Kyere S. K., Joseph P. R. B., Summers M. F., The p12 domain is unstructured in a murine leukemia virus p12-CA(N) Gag construct. PLoS ONE 2008 3 4 2-s2.0-44849091683 10.1371/journal.pone.0001902 e1902
53. Prats A. C., De Billy G., Wang P., Darlix J. L., CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus. Journal of Molecular Biology 1989 205 2 363 372 2-s2.0-0024502074
54. Fujisawa R., McAtee F. J., Favara C., Hayes S. F., Portis J. L., N-terminal cleavage fragment of glycosylated Gag is incorporated into murine oncornavirus particles. Journal of Virology 2001 75 22 11239 11243 2-s2.0-0034761430 10.1128/JVI.75.22.11239-11243.2001
55. Corbin A., Prats A. C., Darlix J. L., Sitbon M., A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. Journal of Virology 1994 68 6 3857 3867 2-s2.0-0028228660
56. Schwartzberg P., Colicelli J., Goff S. P., Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent. Journal of Virology 1983 46 2 538 546 2-s2.0-0020569116
57. Low A., Datta S., Kuznetsov Y., Jahid S., Kothari N., McPherson A., Fan F., Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release. Journal of Virology 2007 81 8 3685 3692 2-s2.0-34247123294 10.1128/JVI.01538-06
58. Nitta T., Tam R., Kim J. W., Fan H., The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag. mBio 2011 2 1 10.1128/mBio.00341-10
59. Pizzato M., MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1. Proceedings of the National Academy of Sciences of the United States of America 2010 107 20 9364 9369 2-s2.0-77952683763 10.1073/pnas.1001554107
60. Gorelick R. J., Fu W., Gagliardi T. D., Bosche W. J., Rein A., Henderson L. E., Arthur L. O., Characterization of the block in replication of nucleocapsid protein zinc finger mutants from Moloney murine leukemia virus. Journal of Virology 1999 73 10 8185 8195 2-s2.0-0032863131
61. Gorelick R. J., Henderson L. E., Hanser J. P., Rein A., Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proceedings of the National Academy of Sciences of the United States of America 1988 85 22 8420 8424 2-s2.0-0024110320
62. Henderson L. E., Sowder R., Copeland T. D., Smythers G., Oroszlan S., Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. Journal of Virology 1984 52 2 492 500
63. Menendez-Arias L., Gotte D., Oroszlan S., Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme. Virology 1993 196 2 557 563 2-s2.0-0027361627 10.1006/viro.1993.1511
64. Swanstrom R., Wills J. W., Coffin J. M., Hughes S. H., Varmus H. E., Synthesis, assembly, and processing of viral proteins. Retroviruses 1997 Plainview, NY, USA Cold Spring Harbor Laboratory Press 263 334
65. Das D., Georgiadis M. M., The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus. Structure 2004 12 5 819 829 2-s2.0-2342566918 10.1016/j.str.2004.02.032
66. Moelling K., Characterization of reverse transcriptase and RNase H from friend-murine leukemia virus. Virology 1974 62 1 46 59 2-s2.0-0016130809
67. Telesnitsky A., Goff S. P., Coffin J. M., Hughes S. H., Varmus H. E., Reverse transcriptase and the generation of retroviral DNA. Retroviruses 1997 Plainview, NY, USA Cold Spring Harbor Laboratory Press 121 160
68. Hare S., Di Nunzio F., Labeja A., Wang J., Engelman A., Cherepanov P., Structural basis for functional tetramerization of lentiviral integrase. PLoS Pathogens 2009 5 7 2-s2.0-70049117341 10.1371/journal.ppat.1000515 e1000515
69. Hare S., Gupta S. S., Valkov E., Engelman A., Cherepanov P., Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 2010 464 7286 232 236 2-s2.0-77949365510 10.1038/nature08784
70. Schultz A., Rein A., Maturation of murine leukemia virus env proteins in the absence of other viral proteins. Virology 1985 145 2 335 339 2-s2.0-0021806159
71. Brody B. A., Rhee S. S., Hunter E., Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. Journal of Virology 1994 68 7 4620 4627 2-s2.0-0028241598
72. Sommerfelt M. A., Petteway S. R. Jr., Dreyer G. B., Hunter E., Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage. Journal of Virology 1992 66 7 4220 4227 2-s2.0-0026764061
73. Rice N. R., Henderson L. E., Sowder R. C., Copeland T. D., Oroszlan S., Edwards J. F., Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. Journal of Virology 1990 64 8 3770 3778 2-s2.0-0025282289
74. Hunter E., Coffin J. M., Hughes S. H., Varmus H. E., Viral entry and receptors. Retroviruses 1997 Plainview, NY, USA Cold Spring Harbor Laboratory Press 71 119
75. Fass D., Davey R. A., Hamson C. A., Kim P. S., Cunningham J. M., Berger J. M., Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 1997 277 5332 1662 1666 2-s2.0-0030820095 10.1126/science.277.5332.1662
76. Fass D., Harrison S. C., Kim P. S., Retrovirus envelope domain at 1.7 Å resolution. Nature Structural Biology 1996 3 5 465 469 2-s2.0-0029914299
77. Kobe B., Center R. L., Kemp B. E., Poumbourios P., Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proceedings of the National Academy of Sciences of the United States of America 1999 96 8 4319 4324 2-s2.0-0033551053 10.1073/pnas.96.8.4319
78. Pinter A., Kopelman R., Li Z., Kayman S. C., Sanders D. A., Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes. Journal of Virology 1997 71 10 8073 8077 2-s2.0-0030842622
79. Freed E. O., Risser R., The role of envelope glycoprotein processing in murine leukemia virus infection. Journal of Virology 1987 61 9 2852 2856 2-s2.0-0023199650
80. Ragheb J. A., Anderson W. F., pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. Journal of Virology 1994 68 5 3220 3231 2-s2.0-0028271720
81. Rein A., Mirro J., Haynes J. G., Ernst S. M., Nagashima K., Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. Journal of Virology 1994 68 3 1773 1781 2-s2.0-0028047579
82. Li M., Li Z. N., Yao Q., Yang C., Steinhauer D. A., Compans R. W., Murine leukemia virus R peptide inhibits influenza virus hemagglutinin-induced membrane fusion. Journal of Virology 2006 80 12 6106 6114 2-s2.0-33744904455 10.1128/JVI.02665-05
83. Wallin M., Ekström M., Garoff H., Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO Journal 2004 23 1 54 65 2-s2.0-0842307062 10.1038/sj.emboj.7600012
84. Li K., Zhang S., Kronqvist M., Ekström M., Wallin M., Garoff H., The conserved His8 of the Moloney murine leukemia virus Env SU subunit directs the activity of the SU-TM disulphide bond isomerase. Virology 2007 361 1 149 160 2-s2.0-34047261817 10.1016/j.virol.2006.11.013
85. Barnett A. L., Cunningham J. M., Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion. Journal of Virology 2001 75 19 9096 9105 2-s2.0-0034849671 10.1128/JVI.75.19.9096-9105.2001
86. Barnett A. L., Davey R. A., Cunningham J. M., Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection. Proceedings of the National Academy of Sciences of the United States of America 2001 98 7 4113 4118 2-s2.0-0035957377 10.1073/pnas.071432398
87. Lavillette D., Ruggieri A., Russell S. J., Cosset F. L., Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. Journal of Virology 2000 74 1 295 304 2-s2.0-0033987002
88. Chattopadhyay S. K., Lander M. R., Rands E., Gupta S., Lowy D. R., Origin of mink cytopathic focus-forming (MCF) viruses: comparison with ecotropic and xenotropic murine leukemia virus genomes. Virology 1981 113 2 465 483 2-s2.0-0019502918
89. Hartley J. W., Wolford N. K., Old L. J., Rowe W. P., A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proceedings of the National Academy of Sciences of the United States of America 1977 74 2 789 792 2-s2.0-0017337438
90. Bosselman R. A., van Straaten F., van Beveren C., Verma I. M., Vogt M., Analysis of the env gene of a molecularly cloned and biologically active Moloney mink cell focus-forming proviral DNA. Journal of Virology 1982 44 1 19 31 2-s2.0-0019992634
91. Rein A., Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells. Virology 1982 120 1 251 257 2-s2.0-0020079047
92. Wensel D. L., Li W., Cunningham J. M., A virus-virus interaction circumvents the virus receptor requirement for infection by pathogenic retroviruses. Journal of Virology 2003 77 6 3460 3469 2-s2.0-0037333415 10.1128/JVI.77.6.3460-3469.2003
93. Cianciolo G. J., Copeland T. D., Oroszlan S., Snyderman R., Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 1985 230 4724 453 455 2-s2.0-0022408821
94. Schlecht-Louf G., Renard M., Mangeney M., Letzelter C., Richaud A., Ducos B., Bouallaga I., Heidmann T., Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses. Proceedings of the National Academy of Sciences of the United States of America 2010 107 8 3782 3787 2-s2.0-77649267384 10.1073/pnas.0913122107
95. Rein A., Schultz A., Different recombinant murine leukemia viruses use different cell surface receptors. Virology 1984 136 1 144 152 2-s2.0-0021153680
96. Tailor C. S., Lavillette D., Marin M., Kabat D., Cell surface receptors for gammaretroviruses. Current Topics in Microbiology and Immunology 2003 281 29 106 2-s2.0-0042164510
97. Temin H. M., Rubin H., Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology 1958 6 3 669 688 2-s2.0-0001726468
98. Rowe W. P., Pugh W. E., Hartley J. W., Plaque assay techniques for murine leukemia viruses. Virology 1970 42 4 1136 1139 2-s2.0-0014898897
99. Bassin R. H., Tuttle N., Fischinger P. J., Rapid cell culture assay technique for murine leukaemia viruses. Nature 1971 229 5286 564 566 2-s2.0-0015231911 10.1038/229564b0
100. Rulli S. J. Jr., Mirro J., Hill S. A., Lloyd P., Gorelick R. J., Coffin J. M., Derse D., Rein A., Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses. Journal of Virology 2008 82 13 6566 6575 2-s2.0-45749088955 10.1128/JVI.01357-07
101. Mazurov D., Ilinskaya A., Heidecker G., Lloyd P., Derse D., Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathogens 2010 6 2 2-s2.0-77649242985 10.1371/journal.ppat.1000788 e1000788
102. Bassin R. H., Ruscetti S., Ali I., Haapala D. K., Rein A., Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection. Virology 1982 123 1 139 151 2-s2.0-0020213610
103. Ikeda H., Odaka T., A cell membrane "gp70" associated with Fv-4 gene: immunological characterization and tissue and strain distribution. Virology 1984 133 1 65 76 2-s2.0-0021345123
104. Pincus T., Rowe W. P., Lilly F., A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus. Journal of Experimental Medicine 1971 133 6 1234 1241 2-s2.0-0015072284
105. Groom H. C. T., Yap M. W., Galão R. P., Neil S. J. D., Bishop K. N., Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proceedings of the National Academy of Sciences of the United States of America 2010 107 11 5166 5171 2-s2.0-77950414085 10.1073/pnas.0913650107
106. Best S., Tissier P. L., Towers G., Stoye J. P., Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 1996 382 6594 826 829 2-s2.0-0029763293 10.1038/382826a0
107. Yap M. W., Stoye J. P., Intracellular localisation of Fv1. Virology 2003 307 1 76 89 2-s2.0-0037347206 10.1016/S0042-6822(02)00053-3
108. Duran-Troise G., Bassin R. H., Rein A., Gerwin B. I., Loss of Fv 1 restriction in Balb/3T3 cells following infection with a single N tropic murine leukemia virus particle. Cell 1977 10 3 479 488 2-s2.0-0017335655
109. Bassin R. H., Duran-Troise G., Gerwin B. I., Rein A., Abrogation of Fv-1(b) restriction with murine leukemia viruses inactivated by heat or by gamma irradiation. Journal of Virology 1978 26 2 306 315 2-s2.0-0018197948
110. Bishop K. N., Mortuza G. B., Howell S., Yap M. W., Stoye J. P., Taylor I. A., Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1. Journal of Virology 2006 80 16 8225 8235 2-s2.0-33746802760 10.1128/JVI.00395-06
111. Yap M. W., Mortuza G. B., Taylor I. A., Stoye J. P., The design of artificial retroviral restriction factors. Virology 2007 365 2 302 314 2-s2.0-34547678252 10.1016/j.virol.2007.04.005
112. Hilditch L., Matadeen R., Goldstone D. C., Rosenthal P. B., Taylor I. A., Stoye J. P., jstoye@nimr.mrc.ac.uk Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1. Proceedings of the National Academy of Sciences of the United States of America 2011 108 14 5771 5776 10.1073/pnas.1100118108
113. Towers G., Bock M., Martin S., Takeuchi Y., Stoye J. P., Danos O., A conserved mechanism of retrovirus restriction in mammals. Proceedings of the National Academy of Sciences of the United States of America 2000 97 22 12295 12299 2-s2.0-0034710884 10.1073/pnas.200286297
114. Harris R. S., Liddament M. T., Retroviral restriction by APOBEC proteins. Nature Reviews Immunology 2004 4 11 868 877 2-s2.0-8544241736 10.1038/nri1489
115. LaRue R. S., Andrésdóttir V., Blanchard Y., Conticello S. G., Derse D., Emerman M., Greene W. C., Jónsson S. R., Landau N. R., Löchelt M., Malik H. S., Malim M. H., Münk C., O'Brien S. J., Pathak V. K., Strebel K., Wain-Hobson S., Yu X. F., Yuhki N., Harris R. S., Guidelines for naming nonprimate APOBEC3 genes and proteins. Journal of Virology 2009 83 2 494 497 2-s2.0-58149517769 10.1128/JVI.01976-08
116. Low A., Okeoma C. M., Lovsin N., de las Heras M., Taylor T. H., Peterlin B. M., Ross S. R., Fan H., Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene. Virology 2009 385 2 455 463 2-s2.0-60749085330 10.1016/j.virol.2008.11.051
117. Okeoma C. M., Lovsin N., Peterlin B. M., Ross S. R., APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 2007 445 7130 927 930 2-s2.0-33847200788 10.1038/nature05540
118. Holmes R. K., Malim M. H., Bishop K. N., APOBEC-mediated viral restriction: not simply editing? Trends in Biochemical Sciences 2007 32 3 118 128 2-s2.0-33847636341 10.1016/j.tibs.2007.01.004
119. Mbisa J. L., Barr R., Thomas J. A., Vandegraaff N., Dorweiler I. J., Svarovskaia E. S., Brown W. L., Mansky L. M., Gorelick R. J., Harris R. S., Engelman A., Pathak V. K., Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. Journal of Virology 2007 81 13 7099 7110 2-s2.0-34250880090 10.1128/JVI.00272-07
120. Langlois M. A., Kemmerich K., Rada C., Neuberger M. S., The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3. Journal of Virology 2009 83 22 11550 11559 2-s2.0-70350312835 10.1128/JVI.01430-09
121. Paprotka T., Venkatachari N. J., Chaipan C., Burdick R., Delviks-Frankenberry K. A., Hu W. S., Pathak V. K., Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. Journal of Virology 2010 84 11 5719 5729 2-s2.0-77951996954 10.1128/JVI.00134-10
122. Stieler K., Fischer N., Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV. PLoS ONE 2010 5 7 2-s2.0-77955398967 10.1371/journal.pone.0011738 e11738
123. Browne E. P., Littman D. R., Species-specific restriction of Apobec3-mediated hypermutation. Journal of Virology 2008 82 3 1305 1313 2-s2.0-38349096771 10.1128/JVI.01371-07
124. Abudu A., Takaori-Kondo A., Izumi T., Shirakawa K., Kobayashi M., Sasada A., Fukunaga K., Uchiyama T., Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. Current Biology 2006 16 15 1565 1570 2-s2.0-33746478595 10.1016/j.cub.2006.06.055
125. Neil S. J. D., Zang T., Bieniasz P. D., Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008 451 7177 425 430 2-s2.0-38549095979 10.1038/nature06553
126. Goffinet C., Schmidt S., Kern C., Oberbremer L., Keppler O. T., Endogenous CD317/tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. Journal of Virology 2010 84 21 11374 11384 2-s2.0-77957962634 10.1128/JVI.01067-10
127. Evans D. T., Serra-Moreno R., Singh R. K., Guatelli J. C., BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends in Microbiology 2010 18 9 388 396 2-s2.0-77956188831 10.1016/j.tim.2010.06.010
128. Goff S. P., Host factors exploited by retroviruses. Nature Reviews Microbiology 2007 5 4 253 263 2-s2.0-33947379083 10.1038/nrmicro1541